December 11, 2025
Headlines

Biocon is considering a merger with Biocon Biologics in a $4.5 billion deal; IPO and share swap option under review – The Economic Times & more related News Here

Time Room01 mins
Biocon is considering a merger with Biocon Biologics in a .5 billion deal; IPO and share swap option under review – The Economic Times & more related News Here

  1. Biocon is considering a merger with Biocon Biologics in a $4.5 billion deal; IPO and share swap options under reviewThe Economic Times
  2. Biocon considering merger with Biocon Biologics after shelving IPO plansoutlookbusiness.com
  3. IPO or merger? Kiran Mazumdar-Shaw invests $4.5 billion in Biocon Biologics. business NewsHindustan Times
  4. Biocon Ltd rose 1.95% for the third consecutive sessionbusiness standard
  5. Biocon share price jumps over 4% to 52-week high on restructuring report; Biologics IPO, merger being reviewedlivemint.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News